DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LY2881835
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Free fatty acid receptor 1 agonist
LY2881835
×
Maximum Phase:
1
First Approval:
None
UNII:
LAD0ZG7FFO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APTO-253
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
APTO-253
×
Maximum Phase:
1
First Approval:
None
UNII:
WB59MRW00U
Molecule Type:
Small molecule
Molecular Formula:
C22H14FN5
Molecular Weight:
367.39
AlogP:
5.26
PSA:
70.25
HBD:
2.0
HBA:
#RotB:
1.0
Source:
GET-73
1
Small molecule
Investigational
Unknown
Unknown
Alcoholism
Unknown
GET-73
×
Maximum Phase:
1
First Approval:
None
UNII:
U5CLZ223FH
Molecule Type:
Small molecule
Molecular Formula:
C13H16F3NO2
Molecular Weight:
275.27
AlogP:
2.75
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
H3B-6527
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
H3B-6527
×
Maximum Phase:
1
First Approval:
None
UNII:
4HTE364XIK
Molecule Type:
Small molecule
Molecular Formula:
C29H34Cl2N8O4
Molecular Weight:
629.55
AlogP:
5.48
PSA:
124.19
HBD:
3.0
HBA:
#RotB:
10.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUTANE
1
Small molecule
Investigational
Unknown
Unknown
Essential Hypertension
Unknown
BUTANE
×
Maximum Phase:
1
First Approval:
None
UNII:
6LV4FOR43R
Molecule Type:
Small molecule
Molecular Formula:
C4H10
Molecular Weight:
58.12
AlogP:
1.81
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
1.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
LY-2874455
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Fibroblast growth factor receptor inhibitor
LY-2874455
×
Maximum Phase:
1
First Approval:
None
UNII:
E9M363811V
Molecule Type:
Small molecule
Molecular Formula:
C21H19Cl2N5O2
Molecular Weight:
444.32
AlogP:
4.76
PSA:
88.85
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
NNZ-2591
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NNZ-2591
×
Maximum Phase:
1
First Approval:
None
UNII:
2T1HU6069S
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O2
Molecular Weight:
194.23
AlogP:
0.05
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LY3031207
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY3031207
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
DANAVOREXTON
1
Small molecule
Investigational
Unknown
Unknown
Idiopathic Hypersomnia; Narcolepsy; Sleep Apnea, Obstructive
Unknown
DANAVOREXTON
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H32N2O5S
Molecular Weight:
424.56
AlogP:
2.88
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
6.0
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
BMS-779788
1
Small molecule
Investigational
Unknown
Unknown
Atherosclerosis
LXR-beta agonist
BMS-779788
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD3514
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
AZD3514
×
Maximum Phase:
1
First Approval:
None
UNII:
127DSS8X7J
Molecule Type:
Small molecule
Molecular Formula:
C25H32F3N7O2
Molecular Weight:
519.57
AlogP:
2.83
PSA:
79.09
HBD:
0.0
HBA:
#RotB:
5.0
Source:
RWJ-67657
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RWJ-67657
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H24FN3O
Molecular Weight:
425.51
AlogP:
5.12
PSA:
50.94
HBD:
1.0
HBA:
#RotB:
7.0
Source:
GSK-424887
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder
Unknown
GSK-424887
×
Maximum Phase:
1
First Approval:
None
UNII:
IYI99KCF2T
Molecule Type:
Small molecule
Molecular Formula:
C27H30ClFN2O
Molecular Weight:
453.0
AlogP:
6.21
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
5.0
Source:
AN-2718
1
Small molecule
Investigational
Unknown
Unknown
Tinea Pedis
Unknown
AN-2718
×
Maximum Phase:
1
First Approval:
None
UNII:
810U6C2DGG
Molecule Type:
Small molecule
Molecular Formula:
C7H6BClO2
Molecular Weight:
168.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MURIZATOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes
Unknown
MURIZATOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C42H57ClN4O5S
Molecular Weight:
765.46
AlogP:
6.44
PSA:
91.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ON123300
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ON123300
×
Maximum Phase:
1
First Approval:
None
UNII:
QJ8RO3296G
Molecule Type:
Small molecule
Molecular Formula:
C24H27N7O
Molecular Weight:
429.53
AlogP:
3.27
PSA:
90.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TAFETINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAFETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
H4X2M2NN5N
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN4O2
Molecular Weight:
424.52
AlogP:
3.73
PSA:
77.23
HBD:
3.0
HBA:
#RotB:
6.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
POLYGLYCONATE
1
Small molecule
Investigational
Unknown
Unknown
Influenza, Human
Unknown
POLYGLYCONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
KOF6AD0GWS
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTODRIMER SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASTODRIMER SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
8Q3B8SV59L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD-4769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
AZD-4769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3S
Molecular Weight:
457.6
AlogP:
6.7
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
11.0
Source:
TROTABRESIB
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Lymphoma, Non-Hodgkin
Unknown
TROTABRESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H21NO4S
Molecular Weight:
383.47
AlogP:
3.4
PSA:
65.37
HBD:
0.0
HBA:
#RotB:
5.0
Source:
1
2
…
70
71
72
73
74
75
76
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA